Scansource, Inc 8-K, filed Feb 2, 2021
Scansource, Inc. (SCSC)
8-K
2021-02-02
For: 2021-02-02
View Original
Added on
April 08, 2026
About this 8-K
Scansource, Inc filed this 8-K on February 2, 2021.
Items reported
- Item 2.02: Financial results
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 2, 2021
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
(Address of principal executive offices, including zip code)
(Registrant’s telephone number, including area code)
| Title of Each Class | Trading Symbol | Name of Each Exchange on Which Registered | ||||||||||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
| Emerging growth company | |||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition
On February 2, 2021 , ScanSource, Inc. (the "Company") issued a press release announcing its financial results for its second quarter ended December 31, 2020. A copy of the press release and accompanying CFO commentary are attached as Exhibits 99.1 and 99.2 hereto and incorporated herein by reference and also made available through the Company’s website at www.scansource.com. An updated investor presentation will be made available on the Company's website within approximately two weeks.
The information in Item 2.02 of this Report, including the exhibits, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any other filing under the Securities Act of 1933 or the Exchange Act.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
99.1 – Press release issued by ScanSource, Inc. on February 2, 2021 . The information contained in the attached exhibit is unaudited and should be read in conjunction with the Company’s annual and quarterly reports filed with the Securities and Exchange Commission.
99.2 – CFO commentary for the financial results conference call held on February 2, 2021 . The information contained in the attached exhibit is unaudited and should be read in conjunction with the Company’s annual and quarterly reports filed with the Securities and Exchange Commission.
| Exhibit Number | Description | ||||
| 99.1 | |||||
| 99.2 | |||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ScanSource, Inc. | |||||||||||||||||||||||
| Date: | By: | /s/ Stephen T. Jones | |||||||||||||||||||||
| Name: | Stephen T. Jones | ||||||||||||||||||||||
| Its: | Senior Executive Vice President and Chief Financial Officer | ||||||||||||||||||||||
Exhibit 99.1
FOR IMMEDIATE RELEASE
| Contact: | ||||||||
| Stephen T. Jones | Mary M. Gentry | |||||||
| Senior Executive Vice President, Chief Financial Officer | - or - | Vice President, Treasurer and Investor Relations | ||||||
| ScanSource, Inc. | ScanSource, Inc. | |||||||
| (864) 286-4302 | (864) 286-4892 | |||||||
SCANSOURCE DELIVERS A STRONG SECOND QUARTER
Net Sales of $811 million with 7% Quarter-Over-Quarter Growth
GREENVILLE, SC -- February 2, 2021 -- ScanSource, Inc. (NASDAQ: SCSC), a leading provider of technology products and solutions, today announced financial results for the second quarter ended December 31, 2020. All results in this release reflect continuing operations only unless otherwise noted.
Second Quarter Summary:
•Net sales: $810.9 million, down 2% year-over-year (up 2% year-over-year for organic growth)
•7% quarter-over-quarter growth for net sales (up from $757.3 million for first quarter of fiscal year 2021)
•Gross profit: $86.0 million, down 12% year-over-year
•GAAP operating income of $17.1 million; non-GAAP operating income of $23.8 million
•Net income from continuing operations of $11.1 million
•GAAP diluted EPS of $0.43 per share; non-GAAP diluted EPS of $0.65 per share
•Generated strong operating cash flow of $44.4 million during the quarter and $215.0 million for the trailing 12-month period
•Return on invested capital increased to 12.4% for the quarter
"Our employees across the company delivered results that exceeded our expectations, even as we are still recovering from the sales impact of the COVID-19 pandemic," said Mike Baur, Chairman and CEO, ScanSource, Inc. "Strong growth drove higher net sales and operating leverage on our SG&A. We are delighted to welcome Steve Jones, our new CFO, to the ScanSource family, as his background is a great fit with our focus on recurring revenue."
Quarterly Results
Net sales totaled $810.9 million for the second quarter of fiscal year 2021, down 2% year-over-year, or up 2% year-over-year for organic growth. The year-over-year reduction in net sales is primarily due to the impact of the COVID-19 pandemic. During the quarter, we saw continued progress in recovering from the sales impact of the COVID-19 pandemic in North America and Brazil. For the Intelisys master agency business, net sales increased 15% year-over-year for the second quarter of fiscal year 2021. ScanSource delivered 7% sequential quarter growth from the September quarter.
For the second quarter of fiscal year 2021, operating income decreased to $17.1 million from $18.6 million for the prior-year quarter, and non-GAAP operating income decreased to $23.8 million from $28.5 million for the prior-year quarter. At the end of July 2020, the Company implemented a $30 million annualized expense reduction program to address the business impacts of the COVID-19 pandemic and prepare for the next phase of growth. Selling, general and administrative expenses for the quarter decreased $7.4 million, and the Company realized the planned quarterly impact of the expense reduction plan.
On a GAAP basis, net income for the second quarter of fiscal year 2021 totaled $11.1 million, or $0.43 per diluted share, compared to net income of $11.6 million, or $0.46 per diluted share, for the prior-year quarter. Non-GAAP net income totaled $16.5 million, or $0.65 per diluted share, compared to $19.4 million, or $0.77 per diluted share, for the prior-year quarter.
At December 31, 2020, ScanSource had cash and cash equivalents of $67.2 million and total debt of $151.9 million. The Company generated $44.4 million of operating cash flow in the second quarter of fiscal year 2021 and $215.0 million for the trailing 12-month period.
1
Exhibit 99.1
Discontinued Operations
On August 20, 2019, ScanSource announced plans to divest its products distribution businesses outside of the United States, Canada and Brazil (the “Divestitures”), as part of a strategic portfolio repositioning to align investments with higher-growth, higher-margin businesses. ScanSource completed the divestitures with the sales of the products distribution business located in Mexico, Colombia, Chile, Peru, and Miami-based export operations on October 30, 2020 and the sale of the Europe and UK products distribution business on November 12, 2020.
COVID-19 Update
Our top priority during the COVID-19 pandemic is protecting the health and safety of our employees. We implemented travel restrictions and transitioned our employees, where possible, to a remote working environment. Most of our office-based employees around the world are working remotely. We have taken a number of measures to ensure our teams have the flexibility and resources they need to stay safe and healthy. We are experiencing higher costs from these safety measures to protect our employees. We are continuing to provide the high level of customer service our partners expect from us.
Webcast Details and CFO Commentary
At approximately 4:15 p.m. ET today, a CFO commentary, as a supplement to this press release and the Company's conference call, will be available on ScanSource's website, www.scansource.com (Investor Relations section). ScanSource will present additional information about its financial results in a conference call today, February 2, 2021, at 5:00 p.m. ET. A webcast of the call will be available for all interested parties and can be accessed at www.scansource.com (Investor Relations section). The webcast will be available for replay for 60 days.
Safe Harbor Statement
This press release contains “forward-looking” statements, including the impact of the COVID-19 pandemic, which involve risks and uncertainties. Any number of factors could cause actual results to differ materially from anticipated results, including, but not limited to, the impact of the COVID-19 pandemic on the Company's operations and financial condition and the potential prolonged economic weakness brought on by COVID-19, the failure to manage and implement the Company's organic growth strategy, credit risks involving the Company's larger customers and suppliers, changes in interest and exchange rates and regulatory regimes impacting the Company's international operations, risk to the Company's business from a cyber-security attack, a failure of the Company's IT systems, failure to hire and retain quality employees, loss of the Company's major customers, termination of the Company's relationship with key suppliers or a significant modification of the terms under which it operates with a key supplier, changes in the Company's operating strategy, and other factors set forth in the "Risk Factors" contained in the Company's annual report on Form 10-K for the year ended June 30, 2020, filed with the Securities and Exchange Commission. Except as may be required by law, the Company expressly disclaims any obligation to update these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.
Non-GAAP Financial Information
In addition to disclosing results that are determined in accordance with United States Generally Accepted Accounting Principles ("GAAP"), the Company also discloses certain non-GAAP financial measures, which are summarized below. Non-GAAP financial measures are used to understand and evaluate performance, including comparisons from period to period. Non-GAAP results exclude amortization of intangible assets related to acquisitions, change in fair value of contingent consideration, acquisition costs, restructuring costs and other non-GAAP adjustments.
Net sales on a constant currency basis, excluding acquisitions: The Company discloses the percentage change in net sales excluding the translation impact from changes in foreign currency exchange rates between reporting periods and excluding the net sales from acquisitions prior to the first full year from the acquisition date. This measure enhances the comparability between periods to help analyze underlying trends on an organic basis.
Income Statement Non-GAAP Metrics: To evaluate current period performance on a more consistent basis with prior periods, the Company discloses non-GAAP net sales, non-GAAP gross profit, non-GAAP operating income, non-GAAP other expense, net, non-GAAP pre-tax income, non-GAAP net income and non-GAAP diluted earnings per share (non-GAAP diluted "EPS"). Non-GAAP results exclude amortization of intangible assets related to acquisitions, changes in fair value of contingent consideration, acquisition and divestiture costs, impairment charges and other non-GAAP adjustments. These year-over-year metrics include the translation impact of changes in foreign currency exchange rates. Non-GAAP metrics are useful in assessing
2
and understanding the Company's operating performance, especially when comparing results with previous periods or forecasting performance for future periods.
Return on invested capital ("ROIC"): ROIC assists management in comparing the Company's performance over various reporting periods on a consistent basis because it removes from our operating results the impact of items that do not reflect our core operating performance. We believe the calculation of ROIC provides useful information to investors and is an additional relevant comparison of our performance. ROIC is calculated as adjusted EBITDA over invested capital. Adjusted earnings before interest expense, income taxes, depreciation and amortization ("Adjusted EBITDA") excludes the change in fair value of contingent consideration, in addition to other non-GAAP adjustments. Invested capital is defined as average equity plus average daily funded interest-bearing debt for the period. Management believes the calculation of ROIC provides useful information to investors and is an additional relevant comparison of the Company's performance during the year.
These non-GAAP financial measures have limitations as analytical tools, and the non-GAAP financial measures that the Company reports may not be comparable to similarly titled amounts reported by other companies. Analysis of results and outlook on a non-GAAP basis should be considered in addition to, and not in substitution for or as superior to, measurements of financial performance prepared in accordance with GAAP. A reconciliation of the Company's non-GAAP financial information to GAAP is set forth in the Supplementary Information (Unaudited) below.
About ScanSource, Inc.
ScanSource, Inc. (NASDAQ: SCSC) is at the center of the technology solution delivery channel, connecting businesses and providing solutions for their complex needs. ScanSource sells through multiple, specialized routes-to-market with digital, physical and services offerings from the world’s leading suppliers of point-of-sale (POS), payments, barcode, physical security, unified communications and collaboration, telecom and cloud services. ScanSource enables its sales partners to create, deliver and manage solutions for end-customers across almost every vertical market. Founded in 1992 and headquartered in Greenville, South Carolina, ScanSource was named one of the Best Places to Work in South Carolina and on FORTUNE magazine’s 2020 List of World’s Most Admired Companies. ScanSource ranks #654 on the Fortune 1000. For more information, visit www.scansource.com.
3
ScanSource Reports Second Quarter Results
| ScanSource, Inc. and Subsidiaries | |||||||||||
| Condensed Consolidated Balance Sheets (Unaudited) | |||||||||||
| (in thousands) | |||||||||||
| December 31, 2020 | June 30, 2020* | ||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 67,187 | $ | 29,485 | |||||||
Accounts receivable, less allowance of $21,805 at December 31, 2020 and $21,906 at December 31, 2019 | 534,583 | 443,185 | |||||||||
| Inventories | 421,003 | 454,885 | |||||||||
| Prepaid expenses and other current assets | 96,358 | 94,681 | |||||||||
| Current assets held for sale | — | 181,231 | |||||||||
| Total current assets | 1,119,131 | 1,203,467 | |||||||||
| Property and equipment, net | 48,183 | 55,641 | |||||||||
| Goodwill | 217,956 | 214,288 | |||||||||
| Identifiable intangible assets, net | 114,208 | 121,547 | |||||||||
| Deferred income taxes | 25,619 | 24,630 | |||||||||
| Other non-current assets | 72,022 | 72,521 | |||||||||
| Total assets | $ | 1,597,119 | $ | 1,692,094 | |||||||
| Liabilities and Shareholders’ Equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 589,292 | $ | 454,240 | |||||||
| Accrued expenses and other current liabilities | 91,592 | 76,686 | |||||||||
| Current portion of contingent consideration | — | 46,334 | |||||||||
| Income taxes payable | 859 | 5,886 | |||||||||
| Current portion of long-term debt | 7,843 | 7,839 | |||||||||
| Current liabilities held for sale | — | 128,022 | |||||||||
| Total current liabilities | 689,586 | 719,007 | |||||||||
| Deferred income taxes | 4,273 | 3,884 | |||||||||
| Long-term debt, net of current portion | 139,081 | 143,175 | |||||||||
| Borrowings under revolving credit facility | 5,000 | 67,714 | |||||||||
| Other long-term liabilities | 77,040 | 80,068 | |||||||||
| Total liabilities | 914,980 | 1,013,848 | |||||||||
| Commitments and contingencies | |||||||||||
| Shareholders’ equity: | |||||||||||
Preferred stock, no par value; 3,000,000 shares authorized, none issued | — | — | |||||||||
Common stock, no par value; 45,000,000 shares authorized, 25,451,640 and 25,361,298 shares issued and outstanding at December 31, 2020 and June 30, 2020, respectively | 65,924 | 63,765 | |||||||||
| Retained earnings | 721,263 | 747,276 | |||||||||
| Accumulated other comprehensive loss | (105,048) | (132,795) | |||||||||
| Total shareholders’ equity | 682,139 | 678,246 | |||||||||
| Total liabilities and shareholders’ equity | $ | 1,597,119 | $ | 1,692,094 | |||||||
*Derived from audited financial statements.
4
ScanSource Reports Second Quarter Results
| ScanSource, Inc. and Subsidiaries | |||||||||||||||||||||||
| Condensed Consolidated Income Statements (Unaudited) | |||||||||||||||||||||||
| (in thousands, except per share data) | |||||||||||||||||||||||
| Quarter ended December 31, | Six months ended December 31, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| Net sales | $ | 810,897 | $ | 823,999 | $ | 1,568,238 | $ | 1,666,700 | |||||||||||||||
| Cost of goods sold | 724,854 | 725,680 | 1,401,415 | 1,469,856 | |||||||||||||||||||
| Gross profit | 86,043 | 98,319 | 166,823 | 196,844 | |||||||||||||||||||
| Selling, general and administrative expenses | 60,470 | 67,840 | 122,580 | 136,371 | |||||||||||||||||||
| Depreciation expense | 3,097 | 3,161 | 6,494 | 6,462 | |||||||||||||||||||
| Intangible amortization expense | 4,862 | 5,310 | 9,716 | 9,848 | |||||||||||||||||||
| Restructuring and other charges | 484 | 266 | 8,753 | 435 | |||||||||||||||||||
| Change in fair value of contingent consideration | — | 3,176 | 516 | 5,649 | |||||||||||||||||||
| Operating income | 17,130 | 18,566 | 18,764 | 38,079 | |||||||||||||||||||
| Interest expense | 1,796 | 3,312 | 3,709 | 6,629 | |||||||||||||||||||
| Interest income | (531) | (740) | (1,011) | (1,548) | |||||||||||||||||||
| Other expense (income), net | 121 | (39) | 484 | 336 | |||||||||||||||||||
| Income before income taxes | 15,744 | 16,033 | 15,582 | 32,662 | |||||||||||||||||||
| Provision for income taxes | 4,683 | 4,407 | 4,636 | 8,745 | |||||||||||||||||||
| Net income from continuing operations | 11,061 | 11,626 | 10,946 | 23,917 | |||||||||||||||||||
| Net loss from discontinued operations | (25,255) | (260) | (36,959) | (1,021) | |||||||||||||||||||
| Net (loss) income | $ | (14,194) | $ | 11,366 | $ | (26,013) | $ | 22,896 | |||||||||||||||
| Per share data: | |||||||||||||||||||||||
| Net income from continuing operations per common share, basic | $ | 0.44 | $ | 0.46 | $ | 0.43 | $ | 0.94 | |||||||||||||||
| Net loss from discontinued operations per common share, basic | (1.00) | (0.01) | (1.46) | (0.04) | |||||||||||||||||||
| Net (loss) income per common share, basic | $ | (0.56) | $ | 0.45 | $ | (1.03) | $ | 0.90 | |||||||||||||||
| Weighted-average shares outstanding, basic | 25,395 | 25,274 | 25,378 | 25,407 | |||||||||||||||||||
| Net income from continuing operations per common share, diluted | $ | 0.43 | $ | 0.46 | $ | 0.43 | $ | 0.94 | |||||||||||||||
| Net loss from discontinued operations per common share, diluted | (0.99) | (0.01) | (1.45) | (0.04) | |||||||||||||||||||
| Net (loss) income per common share, diluted | $ | (0.56) | $ | 0.45 | $ | (1.02) | $ | 0.90 | |||||||||||||||
| Weighted-average shares outstanding, diluted | 25,475 | 25,358 | 25,458 | 25,488 | |||||||||||||||||||
5
ScanSource Reports Second Quarter Results
| ScanSource, Inc. and Subsidiaries | |||||||||||||||||||||||
| Condensed Consolidated Statements of Cash Flows (Unaudited) | |||||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Six months ended December 31, | |||||||||||||||||||||||
| 2020 | 2019 | ||||||||||||||||||||||
| Cash flows from operating activities: | |||||||||||||||||||||||
| Net (loss) income | $ | (26,013) | $ | 22,896 | |||||||||||||||||||
| Net loss from discontinued operations | (36,959) | (1,021) | |||||||||||||||||||||
| Net income from continuing operations | 10,946 | 23,917 | |||||||||||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities of continuing operations: | |||||||||||||||||||||||
| Depreciation and amortization | 17,059 | 17,599 | |||||||||||||||||||||
| Amortization of debt issue costs | 209 | 209 | |||||||||||||||||||||
| Provision for doubtful accounts | (180) | 1,101 | |||||||||||||||||||||
| Share-based compensation | 3,174 | 2,817 | |||||||||||||||||||||
| Deferred income taxes | (694) | (344) | |||||||||||||||||||||
| Change in fair value of contingent consideration | 516 | 5,649 | |||||||||||||||||||||
| Contingent consideration payments excess | (5,457) | (3,050) | |||||||||||||||||||||
| Finance lease interest | 70 | 39 | |||||||||||||||||||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||||||||||||||||||||
| Accounts receivable | (86,683) | 8,101 | |||||||||||||||||||||
| Inventories | 35,124 | (69,384) | |||||||||||||||||||||
| Prepaid expenses and other assets | 2,256 | (1,748) | |||||||||||||||||||||
| Other non-current assets | 1,328 | (8,972) | |||||||||||||||||||||
| Accounts payable | 132,074 | 97,962 | |||||||||||||||||||||
| Accrued expenses and other liabilities | 11,150 | 12,094 | |||||||||||||||||||||
| Income taxes payable | (5,218) | (3,256) | |||||||||||||||||||||
| Net cash provided by operating activities of continuing operations | 115,674 | 82,734 | |||||||||||||||||||||
| Cash flows from investing activities of continuing operations: | |||||||||||||||||||||||
| Capital expenditures | (1,454) | (2,732) | |||||||||||||||||||||
| Cash paid for business acquisitions, net of cash acquired | — | (48,930) | |||||||||||||||||||||
| Proceeds from the sale of net assets of discontinued operations | 34,356 | — | |||||||||||||||||||||
| Net cash provided by (used in) investing activities of continuing operations | 32,902 | (51,662) | |||||||||||||||||||||
| Cash flows from financing activities of continuing operations: | |||||||||||||||||||||||
| Borrowings on revolving credit, net of expenses | 959,848 | 1,022,403 | |||||||||||||||||||||
| Repayments on revolving credit, net of expenses | (1,022,561) | (1,066,890) | |||||||||||||||||||||
| Borrowings on long-term debt, net | (4,089) | (2,210) | |||||||||||||||||||||
| Repayments of finance lease obligations | (652) | (1,115) | |||||||||||||||||||||
| Contingent consideration payments | (41,393) | (35,481) | |||||||||||||||||||||
| Exercise of stock options | — | 720 | |||||||||||||||||||||
| Taxes paid on settlement of equity awards | (1,036) | (1,354) | |||||||||||||||||||||
| Repurchase of common stock | — | (6,077) | |||||||||||||||||||||
| Net cash used in financing activities of continuing operations | (109,883) | (90,004) | |||||||||||||||||||||
6
ScanSource Reports Second Quarter Results
| ScanSource, Inc. and Subsidiaries | |||||||||||||||||||||||
| Condensed Consolidated Statements of Cash Flows (Unaudited), continued | |||||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Cash flows from discontinued operations: | |||||||||||||||||||||||
| Net cash flows provided by operating activities of discontinued operations | 21,704 | 35,326 | |||||||||||||||||||||
| Net cash flows used in investing activities of discontinued operations | (58) | (8) | |||||||||||||||||||||
| Net cash flows (used in) provided by financing activities of discontinued operations | (29,494) | 42,057 | |||||||||||||||||||||
| Net cash flows provided by discontinued operations | (7,848) | 77,375 | |||||||||||||||||||||
| Effect of exchange rate changes on cash and cash equivalents | 1,887 | (256) | |||||||||||||||||||||
| Increase in cash and cash equivalents | 32,732 | 18,187 | |||||||||||||||||||||
| Consolidated cash and cash equivalents at beginning of period | 34,455 | 23,818 | |||||||||||||||||||||
| Consolidated cash and cash equivalents at end of period | 67,187 | 42,005 | |||||||||||||||||||||
| Cash and cash equivalents of discontinued operations | — | 3,232 | |||||||||||||||||||||
| Cash and cash equivalents of continuing operations | $ | 67,187 | $ | 38,773 | |||||||||||||||||||
7
ScanSource Reports Second Quarter Results
| ScanSource, Inc. and Subsidiaries | |||||||||||||||||||||||
| Supplementary Information (Unaudited) | |||||||||||||||||||||||
| (in thousands, except percentages) | |||||||||||||||||||||||
| Non-GAAP Financial Information: | |||||||||||||||||||||||
| Quarter ended December 31, | |||||||||||||||||||||||
| 2020 | 2019 | ||||||||||||||||||||||
Return on invested capital ratio (ROIC), annualized (a) | 12.4 | % | 9.9 | % | |||||||||||||||||||
| Reconciliation of net income to EBITDA: | |||||||||||||||||||||||
| Net income from continuing operations (GAAP) | $ | 11,061 | $ | 11,626 | |||||||||||||||||||
| Plus: Interest expense | 1,796 | 3,312 | |||||||||||||||||||||
| Plus: Income taxes | 4,683 | 4,407 | |||||||||||||||||||||
| Plus: Depreciation and amortization | 8,349 | 9,081 | |||||||||||||||||||||
| EBITDA (non-GAAP) | 25,889 | 28,426 | |||||||||||||||||||||
| Plus: Change in fair value of contingent consideration | — | 3,176 | |||||||||||||||||||||
Plus: Acquisition and divestiture costs(b) | 1,359 | 1,151 | |||||||||||||||||||||
| Plus: Restructuring costs | 484 | 266 | |||||||||||||||||||||
| Adjusted EBITDA (numerator for ROIC) (non-GAAP) | $ | 27,732 | $ | 33,019 | |||||||||||||||||||
| Invested Capital Calculations: | |||||||||||||||||||||||
| Equity – beginning of the period | $ | 671,227 | $ | 905,751 | |||||||||||||||||||
| Equity – end of the period | 682,139 | 927,580 | |||||||||||||||||||||
| Plus: Change in fair value of contingent consideration, net of tax | — | 2,401 | |||||||||||||||||||||
Plus: Acquisition and divestiture costs(b) | 1,359 | 1,151 | |||||||||||||||||||||
| Plus: Restructuring, net of tax | 366 | 196 | |||||||||||||||||||||
| Plus: Discontinued operations net loss | 25,255 | 260 | |||||||||||||||||||||
| Average equity | 690,173 | 918,670 | |||||||||||||||||||||
Average funded debt(c) | 198,620 | 411,614 | |||||||||||||||||||||
| Invested capital (denominator for ROIC) (non-GAAP) | $ | 888,793 | $ | 1,330,284 | |||||||||||||||||||
(a) The annualized EBITDA amount is divided by days in the quarter times 365 days per year, or 366 days for leap year. There were 92 days in the current and prior-year quarter. | |||||||||||||||||||||||
| (b) Acquisition and divestiture costs are generally nondeductible for tax purposes. | |||||||||||||||||||||||
(c) Average funded debt, which includes both continuing and discontinued operations, is calculated as the average daily amounts outstanding on short-term and long-term interest-bearing debt. | |||||||||||||||||||||||
8
ScanSource Reports Second Quarter Results
| ScanSource, Inc. and Subsidiaries | |||||||||||||||||
| Supplementary Information (Unaudited) | |||||||||||||||||
| Net Sales by Segment: | |||||||||||||||||
| Quarter ended December 31, | |||||||||||||||||
| 2020 | 2019 | % Change | |||||||||||||||
| Worldwide Barcode, Networking & Security: | (in thousands) | ||||||||||||||||
| Net sales, reported | $ | 551,394 | $ | 575,001 | (4.1) | % | |||||||||||
Foreign exchange impact (a) | 7,903 | — | |||||||||||||||
| Non-GAAP net sales, constant currency | $ | 559,297 | $ | 575,001 | (2.7) | % | |||||||||||
| Worldwide Communications & Services: | |||||||||||||||||
| Net sales, reported | $ | 259,503 | $ | 248,998 | 4.2 | % | |||||||||||
Foreign exchange impact (a) | 19,882 | — | |||||||||||||||
| Non-GAAP net sales, constant currency | $ | 279,385 | $ | 248,998 | 12.2 | % | |||||||||||
| Consolidated: | |||||||||||||||||
| Net sales, reported | $ | 810,897 | $ | 823,999 | (1.6) | % | |||||||||||
Foreign exchange impact (a) | 27,785 | — | |||||||||||||||
| Non-GAAP net sales, constant currency | $ | 838,682 | $ | 823,999 | 1.8 | % | |||||||||||
(a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2020 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2019. | |||||||||||||||||
| ScanSource, Inc. and Subsidiaries | |||||||||||||||||
| Supplementary Information (Unaudited) | |||||||||||||||||
| Net Sales by Segment: | |||||||||||||||||
| Six months ended December 31, | |||||||||||||||||
| 2020 | 2019 | % Change | |||||||||||||||
| Worldwide Barcode, Networking & Security: | (in thousands) | ||||||||||||||||
| Net sales, reported | $ | 1,074,970 | $ | 1,156,188 | (7.0) | % | |||||||||||
Foreign exchange impact (a) | 15,626 | — | |||||||||||||||
| Non-GAAP net sales, constant currency | $ | 1,090,596 | $ | 1,156,188 | (5.7) | % | |||||||||||
| Worldwide Communications & Services: | |||||||||||||||||
| Net sales, reported | $ | 493,268 | $ | 510,512 | (3.4) | % | |||||||||||
Foreign exchange impact (a) | 37,321 | — | |||||||||||||||
| Non-GAAP net sales, constant currency | $ | 530,589 | $ | 510,512 | 3.9 | % | |||||||||||
| Consolidated: | |||||||||||||||||
| Net sales, reported | $ | 1,568,238 | $ | 1,666,700 | (5.9) | % | |||||||||||
Foreign exchange impact (a) | 52,947 | — | |||||||||||||||
| Non-GAAP net sales, constant currency | $ | 1,621,185 | $ | 1,666,700 | (2.7) | % | |||||||||||
(a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2020 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2019. | |||||||||||||||||
9
ScanSource Reports Second Quarter Results
| ScanSource, Inc. and Subsidiaries | |||||||||||||||||
| Supplementary Information (Unaudited) | |||||||||||||||||
| Net Sales by Geography: | |||||||||||||||||
| Quarter ended December 31, | |||||||||||||||||
| 2020 | 2019 | % Change | |||||||||||||||
| United States and Canada: | (in thousands) | ||||||||||||||||
| Net sales, as reported | $ | 720,004 | $ | 734,832 | (2.0) | % | |||||||||||
| International: | |||||||||||||||||
| Net sales, reported | $ | 90,893 | $ | 89,167 | 1.9 | % | |||||||||||
Foreign exchange impact(a) | 27,785 | — | |||||||||||||||
| Non-GAAP net sales, constant currency | $ | 118,678 | $ | 89,167 | 33.1 | % | |||||||||||
| Consolidated: | |||||||||||||||||
| Net sales, reported | $ | 810,897 | $ | 823,999 | (1.6) | % | |||||||||||
Foreign exchange impact(a) | 27,785 | — | |||||||||||||||
| Non-GAAP net sales, constant currency | $ | 838,682 | $ | 823,999 | 1.8 | % | |||||||||||
(a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended December 31, 2020 into U.S. dollars using the average foreign exchange rates for the quarter ended December 31, 2019. | |||||||||||||||||
| ScanSource, Inc. and Subsidiaries | |||||||||||||||||
| Supplementary Information (Unaudited) | |||||||||||||||||
| Net Sales by Geography: | |||||||||||||||||
| Six months ended December 31, | |||||||||||||||||
| 2020 | 2019 | % Change | |||||||||||||||
| United States and Canada: | (in thousands) | ||||||||||||||||
| Net sales, as reported | $ | 1,403,607 | $ | 1,503,343 | (6.6) | % | |||||||||||
| International: | |||||||||||||||||
| Net sales, reported | $ | 164,631 | $ | 163,357 | 0.8 | % | |||||||||||
Foreign exchange impact(a) | 52,947 | — | |||||||||||||||
| Non-GAAP net sales, constant currency | $ | 217,578 | $ | 163,357 | 33.2 | % | |||||||||||
| Consolidated: | |||||||||||||||||
| Net sales, reported | $ | 1,568,238 | $ | 1,666,700 | (5.9) | % | |||||||||||
Foreign exchange impact(a) | 52,947 | — | |||||||||||||||
| Non-GAAP net sales, constant currency | $ | 1,621,185 | $ | 1,666,700 | (2.7) | % | |||||||||||
| (a) Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the six months ended December 31, 2020 into U.S. dollars using the average foreign exchange rates for the six months ended December 31, 2019. | |||||||||||||||||
10
ScanSource Reports Second Quarter Results
| Quarter ended December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| GAAP Measure | Intangible amortization expense | Change in fair value of contingent consideration | Acquisition and divestiture costs | Restructuring costs | Non-GAAP measure | ||||||||||||||||||||||||||||||||||||||||||||||||
| (in thousands, except per share data) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 810,897 | $ | — | $ | — | $ | — | $ | — | $ | 810,897 | |||||||||||||||||||||||||||||||||||||||||
| Gross profit | 86,043 | — | — | — | — | 86,043 | |||||||||||||||||||||||||||||||||||||||||||||||
| Operating income | 17,130 | 4,862 | — | 1,360 | 484 | 23,836 | |||||||||||||||||||||||||||||||||||||||||||||||
| Other expense, net | 1,386 | — | — | — | — | 1,386 | |||||||||||||||||||||||||||||||||||||||||||||||
| Pre-tax income | 15,744 | 4,862 | — | 1,360 | 484 | 22,450 | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income from continuing operations | 11,061 | 3,682 | — | 1,360 | 366 | 16,469 | |||||||||||||||||||||||||||||||||||||||||||||||
| Diluted EPS from continuing operations | $ | 0.43 | $ | 0.15 | $ | — | $ | 0.06 | $ | 0.01 | $ | 0.65 | |||||||||||||||||||||||||||||||||||||||||
| Quarter ended December 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| GAAP Measure | Intangible amortization expense | Change in fair value of contingent consideration | Acquisition and divestiture costs | Restructuring costs | Non-GAAP measure | ||||||||||||||||||||||||||||||||||||||||||||||||
| (in thousands, except per share data) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 823,999 | $ | — | $ | — | $ | — | $ | — | $ | 823,999 | |||||||||||||||||||||||||||||||||||||||||
| Gross profit | 98,319 | — | — | — | — | 98,319 | |||||||||||||||||||||||||||||||||||||||||||||||
| Operating income | 18,566 | 5,310 | 3,176 | 1,151 | 266 | 28,469 | |||||||||||||||||||||||||||||||||||||||||||||||
| Other expense, net | 2,533 | — | — | — | — | 2,533 | |||||||||||||||||||||||||||||||||||||||||||||||
| Pre-tax income | 16,033 | 5,310 | 3,176 | 1,151 | 266 | 25,936 | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income from continuing operations | 11,626 | 4,032 | 2,401 | 1,151 | 196 | 19,406 | |||||||||||||||||||||||||||||||||||||||||||||||
| Diluted EPS from continuing operations | $ | 0.46 | $ | 0.16 | $ | 0.09 | $ | 0.05 | $ | 0.01 | $ | 0.77 | |||||||||||||||||||||||||||||||||||||||||
11
ScanSource Reports Second Quarter Results
| Six months ended December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported GAAP Measure | Intangible amortization expense | Change in fair value of contingent consideration | Acquisition and divestiture costs | Restructuring costs | Non-GAAP measure | ||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 1,568,238 | $ | — | $ | — | $ | — | $ | — | $ | 1,568,238 | |||||||||||||||||||||||||||||||||||||||||
| Gross profit | 166,823 | — | — | — | — | 166,823 | |||||||||||||||||||||||||||||||||||||||||||||||
| Operating income | 18,764 | 9,716 | 516 | 1,857 | 8,753 | 39,606 | |||||||||||||||||||||||||||||||||||||||||||||||
| Other expense, net | 3,182 | — | — | — | — | 3,182 | |||||||||||||||||||||||||||||||||||||||||||||||
| Pre-tax income | 15,582 | 9,716 | 516 | 1,857 | 8,753 | 36,424 | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income from continuing operations | 10,946 | 7,357 | 390 | 1,857 | 6,617 | 27,167 | |||||||||||||||||||||||||||||||||||||||||||||||
| Diluted EPS from continuing operations | $ | 0.43 | $ | 0.29 | $ | 0.02 | $ | 0.07 | $ | 0.26 | $ | 1.07 | |||||||||||||||||||||||||||||||||||||||||
| Six months ended December 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reported GAAP Measure | Intangible amortization expense | Change in fair value of contingent consideration | Acquisition and divestiture costs | Restructuring costs | Non-GAAP measure | ||||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 1,666,700 | $ | — | $ | — | $ | — | $ | — | $ | 1,666,700 | |||||||||||||||||||||||||||||||||||||||||
| Gross profit | 196,844 | — | — | — | — | 196,844 | |||||||||||||||||||||||||||||||||||||||||||||||
| Operating income | 38,079 | 9,848 | 5,649 | 1,909 | 435 | 55,920 | |||||||||||||||||||||||||||||||||||||||||||||||
| Other expense, net | 5,417 | — | — | — | — | 5,417 | |||||||||||||||||||||||||||||||||||||||||||||||
| Pre-tax income | 32,662 | 9,848 | 5,649 | 1,909 | 435 | 50,503 | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income from continuing operations | 23,917 | 7,438 | 4,270 | 1,909 | 324 | 37,858 | |||||||||||||||||||||||||||||||||||||||||||||||
| Diluted EPS from continuing operations | $ | 0.94 | $ | 0.29 | $ | 0.17 | $ | 0.07 | $ | 0.01 | $ | 1.48 | |||||||||||||||||||||||||||||||||||||||||
12
ScanSource Reports Second Quarter Results
| ScanSource, Inc. and Subsidiaries | |||||||||||||||||||||||
| Supplementary Information (Unaudited) | |||||||||||||||||||||||
| Discontinued Operations - Financial Results: | |||||||||||||||||||||||
| Quarter ended December 31, | Six months ended December 31, | ||||||||||||||||||||||
| 2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||
| Net sales | $ | 68,323 | $ | 155,912 | $ | 213,373 | $ | 311,628 | |||||||||||||||
| Cost of goods sold | 63,977 | 140,347 | 198,512 | 282,489 | |||||||||||||||||||
| Gross profit | 4,346 | 15,565 | 14,861 | 29,139 | |||||||||||||||||||
| Selling, general and administrative expenses | 6,378 | 15,016 | 17,291 | 28,825 | |||||||||||||||||||
| Depreciation expense | — | 298 | — | 546 | |||||||||||||||||||
| Intangible amortization expense | — | 321 | — | 746 | |||||||||||||||||||
| Operating loss | (2,032) | (70) | (2,430) | (978) | |||||||||||||||||||
| Interest expense, net | 269 | 430 | 394 | 913 | |||||||||||||||||||
| Loss on disposal group | 23,122 | — | 33,808 | — | |||||||||||||||||||
| Other expense, net | (181) | (188) | 310 | (531) | |||||||||||||||||||
| Loss from discontinued operations before taxes | (25,242) | (312) | (36,942) | (1,360) | |||||||||||||||||||
| Income tax expense | 13 | (52) | 17 | (339) | |||||||||||||||||||
| Net loss from discontinued operations | $ | (25,255) | $ | (260) | $ | (36,959) | $ | (1,021) | |||||||||||||||
13
ScanSource Reports Second Quarter Results
| ScanSource, Inc. and Subsidiaries | |||||||||||
| Supplementary Information (Unaudited) | |||||||||||
| Discontinued Operations - Assets and Liabilities: | |||||||||||
| December 31, 2020 | June 30, 2020 | ||||||||||
| (in thousands) | |||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | — | $ | 4,970 | |||||||
| Accounts receivable, net | — | 117,200 | |||||||||
| Inventories, net | — | 106,779 | |||||||||
| Prepaid expenses and other current assets | — | 23,808 | |||||||||
| Total current assets | — | 252,757 | |||||||||
| Property and equipment, net | — | 1,833 | |||||||||
| Deferred income taxes | — | 9,349 | |||||||||
| Other non-current assets | — | 6,215 | |||||||||
| Total assets, before valuation allowance | — | 270,154 | |||||||||
| Less: valuation allowance | — | (88,923) | |||||||||
Total assets, net of valuation allowance (a) | $ | — | $ | 181,231 | |||||||
| Liabilities | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | — | $ | 56,098 | |||||||
| Accrued expenses and other current liabilities | — | 14,815 | |||||||||
| Other taxes payable | — | 20,378 | |||||||||
| Short-term borrowings | — | 3,524 | |||||||||
| Income tax payable | — | 1,085 | |||||||||
| Total current liabilities | — | 95,900 | |||||||||
| Borrowings under revolving credit facility | — | 24,704 | |||||||||
| Other long-term liabilities | — | 7,418 | |||||||||
Total liabilities(1) | $ | — | $ | 128,022 | |||||||
(a) Total assets and liabilities of discontinued operations are classified in current assets and liabilities, respectively, in the Company's consolidated balance sheet as of December 31, 2020 and June 30, 2020. The discontinued operations were disposed of during the quarter ended December 31, 2020. | |||||||||||
14
CFO COMMENTARY Q2 FY2021 ScanSource, Inc. scansource.com FINANCIAL INFORMATION AND CONFERENCE CALL Please see the accompanying earnings press release available at www.scansource.com in the Investor Relations section. The information included in this CFO commentary is unaudited and should be read in conjunction with the Company’s SEC filings on Form 10-Q for the quarter ended December 31, 2020. All results reflect continuing operations only unless otherwise noted. ScanSource will present additional information about its financial results and outlook in a conference call on Tuesday, February 2, 2021 at 5:00 pm ET. A webcast of the call is available and can be accessed at www.scansource.com (Investor Relations section). The webcast will be available for replay for 60 days. SECOND QUARTER SUMMARY For the second quarter of our fiscal year, we continued to build back sales volumes with 7% Q/Q sales growth and gained operating leverage on SG&A expenses. We realized the planned quarterly impact of the expense reduction plan we announced in July. We delivered net sales of $810.9 million (down 2% Y/Y, or up 2% Y/Y for organic growth). We saw continued progress in recovering from the sales impact of the COVID-19 pandemic in North America and Brazil. As expected, Intelisys net sales grew 15% Y/Y. The gross profit margin was lower than expected due to sales mix and vendor program recognition. We strengthened our balance sheet, reducing working capital by $22 million Q/Q (down $181 million Y/Y) and generating strong cash flow of $44 million for the quarter and $215 million for the trailing 12-month period. For the quarter, our return on invested capital (ROIC) increased to 12.4%. During the quarter, we completed the sale of our products distribution businesses in Latin America (on 10/30/20) and in Europe and the UK (on 11/12/20). CFO COMMENTARY Q2 FY 2021 February 2, 20211 Please see the Appendix for calculation of non- GAAP measures and reconciliations to GAAP measures. Q2 FY2021: Stronger sales growth than expected Exhibit 99.2
CFO COMMENTARY Q2 FY2021 ScanSource, Inc. scansource.com Q2 FY21 Q1 FY21 Q2 FY20 Q/Q Change Y/Y Change Net sales $810.9 $757.3 $824.0 +7% -2% Gross profit $86.0 $80.8 $98.3 +7% -12% Gross profit margin % 10.6% 10.7% 11.9% -6 bps -132 bps SG&A expenses $60.5 $62.1 $67.8 -3% -11% Non-GAAP SG&A expenses $59.1 $61.6 $66.7 -4% -11% Operating income $17.1 $1.6 $18.6 n/m -8% Operating income % 2.1% 0.2% 2.3% n/m -14 bps Non-GAAP operating income $23.8 $15.8 $28.5 +51% -16% Non-GAAP operating income % 2.9% 2.1% 3.5% +86 bps -51 bps GAAP net income $11.1 ($0.1) $11.6 n/m -5% Non-GAAP net income $16.5 $10.7 $19.4 +54% -15% GAAP diluted EPS $0.43 ($0.01) $0.46 n/m -7% Non-GAAP diluted EPS $0.65 $0.42 $0.77 +55% -16% $ in millions, except EPS February 2, 2021 QUARTERLY HIGHLIGHTS Organic growth, a non-GAAP measure, reflects reported sales growth less impacts from foreign currency translation and acquisitions. Non-GAAP operating income, non-GAAP net income, and non-GAAP diluted EPS exclude amortization of intangibles, change in fair value of contingent consideration, impairment charges, restructuring charges, acquisition/divestiture costs, and other non-GAAP items. 2 • Net sales of $810.9 million; up 7% Q/Q and down 2% Y/Y - FX impact of ($28) million; organic growth up 2% Y/Y - Volume increases across most technologies; record net sales in Brazil - Intelisys recurring revenue increased approximately 15% Y/Y • Gross profit margin of 10.6% - Reflects lower supplier program recognition - Lower margin sales mix, including large deals • Non-GAAP operating income of $23.8 million - Y/Y decrease from lower sales volume and lower margin - Partially offset by lower SG&A expense • SG&A expenses down 11% Y/Y - SG&A reflects realization of $30 million annualized expense reduction program • GAAP diluted EPS of $0.43 and non- GAAP diluted EPS of $0.65
CFO COMMENTARY Q2 FY2021 ScanSource, Inc. scansource.com Q2 FY21 Q1 FY21 Q2 FY20 Net sales $551.4 $523.6 $575.0 Gross profit $42.7 $41.1 $51.1 Gross profit margin % 7.7% 7.8% 8.9% Operating income $5.9 $2.1 $13.3 Operating income % 1.1% 0.4% 2.3% Non-GAAP operating income $7.9 $4.1 $15.3 Non-GAAP operating income % 1.4% 0.8% 2.7% 1 February 2, 2021 WORLDWIDE BARCODE, NETWORKING & SECURITY • Net sales of $551 million; up 5% Q/Q and down 4% Y/Y (organic growth down 3% Y/Y) - Growth across key technologies including mobility, self-checkout, video surveillance and networking - Strong growth in Brazil • Gross profit margin of 7.7%, down both Y/Y and Q/Q - Lower supplier program recognition - Lower margin sales mix, including large deals • Operating income of $7.9 million - Y/Y reflects lower gross profits from lower sales volumes and gross margin declines $575 $489 $448 $524 $551 $300 $400 $500 $600 $700 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Net Sales, $ in millions Y/Y Growth -4% Y/Y Organic Growth -3% $ in millions Organic growth, a non-GAAP measure, reflects reported sales growth less impacts from foreign currency translation and acquisitions. Non-GAAP operating income excludes amortization of intangibles, impairment charges and other non-GAAP items. 3
CFO COMMENTARY Q2 FY2021 ScanSource, Inc. scansource.com Q2 FY21 Q1 FY21 Q2 FY20 Net sales $259.5 $233.8 $249.0 Gross profit $43.4 $39.7 $47.2 Gross profit margin % 16.7% 17.0% 19.0% Operating income $13.1 $8.3 $6.4 Operating income % 5.0% 3.5% 2.6% Non-GAAP operating income $16.0 $11.7 $13.2 Non-GAAP operating income % 6.2% 5.0% 5.3% February 2, 2021 WORLDWIDE COMMUNICATIONS & SERVICES $249 $255 $189 $234 $260 $- $100 $200 $300 $400 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Net Sales, $ in millions Y/Y Growth +4% Y/Y Organic Growth +12% $ in millions • Net sales of $260 million; up 11% Q/Q and up 4% Y/Y (organic growth up 12% Y/Y) - For communications, growth in cloud solutions, cloud-enabled endpoints and headsets - Strong growth in Brazil - Record net sales for Intelisys master agency, up 15% Y/Y • Gross profit margin of 16.7% - Lower supplier program recognition - Lower margin sales mix • Non-GAAP operating income of $16.0 million (+21% Y/Y) - Higher sales volumes - Lower SG&A expenses 4 Organic growth, a non-GAAP measure, reflects reported sales growth less impacts from foreign currency translation and acquisitions. Non-GAAP operating income excludes amortization of intangibles, change in fair value of contingent consideration, impairment charges, and other non-GAAP items.
CFO COMMENTARY Q2 FY2021 ScanSource, Inc. scansource.com Q2 FY21 Q1 FY21 Q2 FY20 Accounts receivable (Q/E) $534.6 $509.8 $513.6 Days sales outstanding in receivables 60 61 56 Inventory (Q/E) $421.0 $423.1 $621.1 Inventory turns 6.9 6.2 4.8 Accounts payable (Q/E) $589.3 $544.9 $587.0 Paid for inventory days* (11.8) (7.2) 12.2 Working capital (Q/E) (AR+INV–AP) $366.3 $388.0 $547.8 February 2, 2021 WORKING CAPITAL • Working capital of $366.3 million, down 6% Q/Q and down 33% Y/Y • Days sales outstanding in receivables of 60 days, in line with typical levels • Inventory of $421.0 million, down 32% Y/Y - Inventory turns increased to 6.9x • Paid for inventory days of (11.8) driven by reduction in inventory and timing of accounts payable • Cash conversion cycle improves to 48 days (down from 54 for previous quarter and 68 for previous year) $ in millions * Paid for inventory days represent Q/E inventory days less Q/E accounts payable days 5
CFO COMMENTARY Q2 FY2021 ScanSource, Inc. scansource.com Q2 FY21 Q1 FY21 Q2 FY20 Adjusted EBITDA (QTR)* $27.7 $19.7 $33.0 Adjusted ROIC (QTR)* 12.4% 8.4% 9.9% Operating cash flow (QTR) $44.4 $71.2 $55.1 Operating cash flow, trailing 12 months $215.0 $225.6 $134.9 Cash and cash equivalents (Q/E), including discontinued operations $67.2 $55.6 $42.0 Debt (Q/E), including discontinued operations $151.9 $168.7 $357.7 Net debt, including discontinued operations to adjusted EBITDA, trailing 12 months* 1.1x 1.3x 2.3x February 2, 2021 CASH FLOW AND BALANCE SHEET HIGHLIGHTS • Adjusted EBITDA of $27.7 million - Up 40% Q/Q from higher sales volumes and lower SG&A expenses - Down 16% Y/Y primarily from lower sales volumes and lower gross profit margins • Operating cash flow of $44.4 million for the quarter and $215.0 million for the trailing-12 months - Primarily from lower working capital, including higher accounts payable and lower inventory • Cash and cash equivalent balances of $67.2 million at 12/31/20, including $48.5 million held outside of the U.S. • Net debt to trailing 12-month adjusted EBITDA is 1.1x $ in millions * Excludes non-GAAP adjustments and change in fair value of contingent consideration 6
CFO COMMENTARY Q2 FY2021 ScanSource, Inc. scansource.com FORWARD-LOOKING STATEMENTS This CFO Commentary contains certain comments that are “forward-looking” statements, including statements about the impact of the COVID-19 pandemic and our operating strategies that involve plans, strategies, economic performance and trends, projections, expectations, costs or beliefs about future events and other statements that are not descriptions of historical facts. Forward-looking information is inherently subject to risks and uncertainties. Any number of factors could cause actual results to differ materially from anticipated or forecasted results, including but not limited to, the impact of the COVID-19 pandemic on our operations and financial condition and the potential prolonged economic weakness brought on by COVID-19, the failure to manage and implement our organic growth strategy, credit risks involving our larger customers and suppliers, changes in interest and exchange rates and regulatory regimes impacting our international operations, risk to our business from a cyber-security attack, a failure of our IT systems, failure to hire and retain quality employees, loss of our major customers, termination of our relationship with key suppliers or a significant modification of the terms under which we operate with a key supplier, changes in our operating strategy, and other factors set forth in the “Risk Factors” contained in our annual report on Form 10-K for the year ended June 30, 2020, and subsequent reports on Form 10-Q, filed with the Securities and Exchange Commission (“SEC”). Although ScanSource believes the expectations in its forward-looking statements are reasonable, it cannot guarantee future results, levels of activity, performance or achievement. ScanSource disclaims any obligation to update or revise any forward- looking statements, whether as a result of new information, future events, or otherwise, except as may be required by law. NON-GAAP FINANCIAL INFORMATION In addition to disclosing results that are determined in accordance with United States Generally Accepted Accounting Principles (“GAAP”), the Company also discloses certain non-GAAP measures, including non-GAAP operating income, non-GAAP operating income margin, non-GAAP net income, non- GAAP diluted EPS, non-GAAP net sales, non- GAAP gross profit, non-GAAP gross margin, non-GAAP SG&A expenses, adjusted EBITDA, ROIC and net sales excluding the Divestitures less impacts from foreign currency translation and acquisitions (organic growth). A reconciliation of the Company's non-GAAP financial information to GAAP financial information is provided in the Appendix and in the Company’s Form 8-K, filed with the SEC, with the quarterly earnings press release for the period indicated. February 2, 20217
5-Quarter Financial Summary - for continuing operations ($ in thousands, except per share data) Q2 FY21 Q1 FY21 Q4 FY20 Q3 FY20 Q2 FY20 Q/Q Y/Y Select reported GAAP measures: Net sales $ 810,897 $ 757,342 $ 636,450 $ 744,584 $ 823,999 7% (2)% Gross profit $ 86,043 $ 80,779 $ 74,147 $ 84,579 $ 98,319 7% (12)% Gross profit margin % 10.6 % 10.7 % 11.7 % 11.4 % 11.9 % (6) bp (132) bp SG&A expenses $ 60,470 $ 62,112 $ 58,192 $ 65,140 $ 67,840 (3)% (11)% Operating income (loss) $ 17,130 $ 1,634 $ (113,439) $ 10,393 $ 18,566 n/m (8)% Operating income (loss) % 2.11 % 0.22 % (17.82) % 1.40 % 2.25 % n/m (14) bp Net income (loss) $ 11,061 $ (115) $ (108,859) $ 5,715 $ 11,626 n/m (5)% Diluted EPS $ 0.43 $ (0.01) $ (4.29) $ 0.22 $ 0.46 n/m (7)% Select reported Non-GAAP measures: (a) Net sales $ 810,897 $ 757,342 $ 636,450 $ 744,584 $ 823,999 7% (2)% Gross profit $ 86,043 $ 80,779 $ 74,147 $ 84,579 $ 98,319 7% (12)% Gross profit margin % 10.6 % 10.7 % 11.7 % 11.4 % 11.9 % (6) bp (132) bp Non-GAAP SG&A expenses $ 59,110 $ 61,614 $ 62,624 $ 66,679 $ 66,689 (4)% (11)% Non-GAAP Operating income $ 23,836 $ 15,769 $ 8,219 $ 14,800 $ 28,469 51% (16)% Non-GAAP Operating income % 2.94 % 2.08 % 1.29 % 1.99 % 3.45 % 86 bp (52) bp Non-GAAP Net income $ 16,469 $ 10,698 $ 4,857 $ 9,243 $ 19,406 54% (15)% Non-GAAP Diluted EPS $ 0.65 $ 0.42 $ 0.19 $ 0.35 $ 0.77 55% (16)% Adjusted EBITDA $ 27,732 $ 19,743 $ 12,321 $ 19,845 $ 33,019 40% (16)% Adjusted ROIC 12.4 % 8.4 % 4.0 % 6.0 % 9.9 % 393 bp 251 bp Operating cash flow (QTR) $ 44,449 $ 71,225 $ 73,953 $ 25,348 $ 55,104 (38)% (19)% Operating cash flow (TTM) $ 214,975 $ 225,630 $ 182,035 $ 142,534 $ 134,948 (5)% 59% (a) See page 9 through 11 of the Appendix for the calculation of non-GAAP measures and reconciliations to GAAP measures. ScanSource, Inc. CFO COMMENTARY Q2 FY2021 APPENDIX: RECONCILIATIONS FOR NON-GAAP FINANCIAL INFORMATION scansource.com 8 February 2, 2021
Operating Income, Pre-Tax Income, Net Income & EPS - QTR ($ in thousands) Quarter ended December 31, 2020 Reported GAAP measure Intangible amortization expense Change in fair value of contingent consideration Acquisition, divestiture and restructuring costs(a) Tax recovery, net Impairment charges Non-GAAP measure Net sales $ 810,897 $ — $ — $ — $ — $ — $ 810,897 Gross profit 86,043 — — — — — 86,043 SG&A expenses 60,470 — — (1,360) — — 59,110 Operating income 17,130 4,862 — 1,844 — — 23,836 Other expense, net 1,386 — — — — — 1,386 Pre-tax income 15,744 4,862 — 1,844 — — 22,450 Net income 11,061 3,682 — 1,726 — — 16,469 Diluted EPS $ 0.43 $ 0.15 $ — $ 0.07 $ — $ — $ 0.65 (a) Acquisition and divestiture costs totaled $1.4 million for the quarter ended December 31, 2020 and are generally nondeductible for tax purposes. Restructuring costs totaled $0.5 million for the quarter ended December 31, 2020. ($ in thousands) Quarter ended September 30, 2020 Reported GAAP measure Intangible amortization expense Change in fair value of contingent consideration Acquisition, divestiture and restructuring costs(a) Tax recovery, net Impairment charges Non-GAAP measure Net sales $ 757,342 $ — $ — $ — $ — $ — $ 757,342 Gross profit 80,779 — — — — — 80,779 SG&A expenses 62,112 — — (498) — — 61,614 Operating income 1,634 4,853 516 8,766 — — 15,769 Other expense, net 1,796 — — — — — 1,796 Pre-tax (loss) income (162) 4,853 516 8,766 — — 13,973 Net (loss) income (115) 3,675 390 6,748 — — 10,698 Diluted EPS $ (0.01) $ 0.14 $ 0.02 $ 0.27 $ — $ — $ 0.42 (a) Acquisition and divestiture costs totaled $0.5 million for the quarter ended September 30, 2020 and are generally nondeductible for tax purposes. Restructuring costs totaled $8.3 million for the quarter ended September 30, 2020. ScanSource, Inc. CFO COMMENTARY Q2 FY2021 APPENDIX: RECONCILIATIONS FOR NON-GAAP FINANCIAL INFORMATION scansource.com 9 February 2, 2021
Operating Income, Pre-Tax Income, Net Income & EPS - QTR, continued ($ in thousands) Quarter ended June 30, 2020 Reported GAAP measure Intangible amortization expense Change in fair value of contingent consideration Acquisition, divestiture and restructuring costs(a) Tax recovery, net Impairment charges Non-GAAP measure Net sales $ 636,450 $ — $ — $ — $ — $ — $ 636,450 Gross profit 74,147 — — — — — 74,147 SG&A expenses 58,192 — — (1,311) 5,743 — 62,624 Operating (loss) income (113,439) 4,946 674 1,311 (5,743) 120,470 8,219 Other expense, net (489) — — — 2,681 — 2,192 Pre-tax (loss) income (112,950) 4,946 674 1,311 (8,424) 120,470 6,027 Net (loss) income (108,859) 3,744 510 1,311 (6,247) 114,398 4,857 Diluted EPS $ (4.29) $ 0.15 $ 0.02 $ 0.05 $ (0.25) $ 4.51 $ 0.19 (a) Acquisition and divestiture costs totaled $1.3 million for the quarter ended June 30, 2020 and are generally nondeductible for tax purposes. ($ in thousands) Quarter ended March 31, 2020 Reported GAAP measure Intangible amortization expense Change in fair value of contingent consideration Acquisition, divestiture and restructuring costs(a) Tax recovery, net Impairment charges Non-GAAP measure Net sales $ 744,584 $ — $ — $ — $ — $ — $ 744,584 Gross profit 84,579 — — — — — 84,579 SG&A expenses 65,140 — — (781) 2,320 — 66,679 Operating income 10,393 5,159 618 950 (2,320) — 14,800 Other expense, net 1,881 — — — — — 1,881 Pre-tax income 8,513 5,159 618 950 (2,320) — 12,920 Net income 5,715 3,909 467 906 (1,754) — 9,243 Diluted EPS $ 0.22 $ 0.15 $ 0.02 $ 0.04 $ (0.07) $ — $ 0.35 (a) Acquisition and divestiture costs totaled $0.8 million for the quarter ended March 31, 2020 and are generally nondeductible for tax purposes. Restructuring costs totaled $0.2 million for the quarter ended March 31, 2020. ScanSource, Inc. CFO COMMENTARY Q2 FY2021 APPENDIX: RECONCILIATIONS FOR NON-GAAP FINANCIAL INFORMATION scansource.com 10 February 2, 2021
Operating Income, Pre-Tax Income, Net Income & EPS - QTR, continued ($ in thousands) Quarter ended December 31, 2019 Reported GAAP measure Intangible amortization expense Change in fair value of contingent consideration Acquisition, divestiture and restructuring costs(a) Tax recovery, net Impairment charges Non-GAAP measure Net sales $ 823,999 $ — $ — $ — $ — $ — $ 823,999 Gross profit 98,319 — — — — — 98,319 SG&A expenses 67,840 — — (1,151) — — 66,689 Operating income 18,566 5,310 3,176 1,417 — — 28,469 Other expense, net 2,533 — — — — — 2,533 Pre-tax income 16,033 5,310 3,176 1,417 — — 25,936 Net income 11,626 4,032 2,401 1,347 — — 19,406 Diluted EPS $ 0.46 $ 0.16 $ 0.09 $ 0.06 $ — $ — $ 0.77 (a) Acquisition and divestiture costs totaled $1.2 million for the quarter ended December 31, 2019 and are generally nondeductible for tax purposes. Restructuring costs totaled $0.3 million for the quarter ended December 31, 2019. ScanSource, Inc. CFO COMMENTARY Q2 FY2021 APPENDIX: RECONCILIATIONS FOR NON-GAAP FINANCIAL INFORMATION scansource.com 11 February 2, 2021
Net Sales, Constant Currency and Excluding Acquisitions (Organic Growth) - QTR ($ in thousands) WW Barcode, NW & Security WW Comms. & Services Consolidated For the quarter ended December 31, 2020: Q2 FY21 net sales, as reported $ 551,394 $ 259,503 $ 810,897 Foreign exchange impact (a) 7,903 19,882 27,785 Q2 FY21 net sales, constant currency (non-GAAP) $ 559,297 $ 279,385 $ 838,682 For the quarter ended December 31, 2019: Q2 FY20 net sales, as reported $ 575,001 $ 248,998 $ 823,999 Y/Y % Change: As reported (4.1) % 4.2 % (1.6) % Constant currency (non-GAAP) (2.7) % 12.2 % 1.8 % (a) Year-over-year sales growth excluding the translation impact of changes in foreign currency rates. Calculated by translating net sales for the quarter ended December 31, 2020 into U.S. dollars using the weighted-average foreign exchange rates for the quarter ended December 31, 2019. ScanSource, Inc. CFO COMMENTARY Q2 FY2021 APPENDIX: RECONCILIATIONS FOR NON-GAAP FINANCIAL INFORMATION scansource.com 12 February 2, 2021
Highlights by Segment - QTR ($ in thousands) Quarter Ended December 31, 2020 Reported GAAP measure Intangible amortization expense Change in fair value of contingent consideration Acquisition, Divestiture, and Restructuring costs Tax recovery, net Impairment charges Non-GAAP measure Worldwide Barcode, NW & Security: Net sales 551,394 — — — — — $ 551,394 Gross Profit 42,685 — — — — — $ 42,685 Gross profit margin % 7.7 % — % — % — % — % — % 7.7 % Operating income 5,887 1,968 — — — — $ 7,855 Operating income margin % 1.1 % — % — % — % — % — % 1.4 % Worldwide Communications & Services: Net sales 259,503 — — — — — $ 259,503 Gross Profit 43,358 — — — — — $ 43,358 Gross profit margin % 16.7 % — % — % — % — % — % 16.7 % Operating income 13,087 2,894 — — — — $ 15,981 Operating income margin % 5.0 % — % — % — % — % — % 6.2 % ($ in thousands) Quarter Ended September 30, 2020 Reported GAAP measure Intangible amortization expense Change in fair value of contingent consideration Acquisition, Divestiture, and Restructuring costs Tax recovery, net Impairment charges Non-GAAP measure Worldwide Barcode, NW & Security: Net sales 523,577 — — — — — $ 523,577 Gross Profit 41,085 — — — — — $ 41,085 Gross profit margin % 7.8 % — % — % — % — % — % 7.8 % Operating income 2,147 1,968 — — — — $ 4,115 Operating income margin % 0.4 % — % — % — % — % — % 0.8 % ScanSource, Inc. CFO COMMENTARY Q2 FY2021 APPENDIX: RECONCILIATIONS FOR NON-GAAP FINANCIAL INFORMATION scansource.com 13 February 2, 2021
Highlights by Segment - QTR, continued ($ in thousands) Quarter Ended September 30, 2020 Reported GAAP measure Intangible amortization expense Change in fair value of contingent consideration Acquisition, Divestiture, and Restructuring costs Tax recovery, net Impairment charges Non-GAAP measure Worldwide Communications & Services: Net sales 233,765 — — — — — $ 233,765 Gross Profit 39,694 — — — — — $ 39,694 Gross profit margin % 17.0 % — % — % — % — % — % 17.0 % Operating income 8,253 2,885 516 — — — $ 11,654 Operating income margin % 3.5 % — % — % — % — % — % 5.0 % ($ in thousands) Quarter Ended December 31, 2019 Reported GAAP measure Intangible amortization expense Change in fair value of contingent consideration Acquisition, Divestiture, and Restructuring costs Tax recovery, net Impairment charges Non-GAAP measure Worldwide Barcode, NW & Security: Net sales 575,001 — — — — — $ 575,001 Gross Profit 51,133 — — — — — $ 51,133 Gross profit margin % 8.9 % — % — % — % — % — % 8.9 % Operating income 13,302 1,968 — — — — $ 15,270 Operating income margin % 2.3 % — % — % — % — % — % 2.7 % Worldwide Communications & Services: Net sales 248,998 — — — — — $ 248,998 Gross Profit 47,186 — — — — — $ 47,186 Gross profit margin % 19.0 % — % — % — % — % — % 19.0 % Operating income 6,415 3,342 3,176 266 — — $ 13,199 Operating income margin % 2.6 % — % — % — % — % — % 5.3 % ScanSource, Inc. CFO COMMENTARY Q2 FY2021 APPENDIX: RECONCILIATIONS FOR NON-GAAP FINANCIAL INFORMATION scansource.com 14 February 2, 2021
Average Return on Invested Capital - QTR ($ in thousands) Q2 FY21 Q1 FY21 Q4 FY20 Q3 FY20 Q2 FY20 Adjusted return on invested capital (ROIC), annualized (a) 12.4 % 8.4 % 4.0 % 6.0 % 9.9 % Reconciliation of Net Income to Adjusted EBITDA Net income (loss) from continuing operations - GAAP $ 11,061 $ (115) $ (108,859) $ 5,716 $ 11,626 Plus: Interest expense 1,796 1,913 2,497 3,098 3,312 Income taxes 4,683 (47) (4,091) 2,797 4,407 Depreciation and amortization 8,349 8,710 8,743 8,986 9,081 EBITDA 25,889 10,461 (101,710) 20,597 28,426 Adjustments: Change in fair value of contingent consideration — 516 674 618 3,176 Tax recovery, net — — (8,424) (2,320) — Acquisition and divestiture costs 1,359 498 1,311 781 1,151 Restructuring costs 484 8,268 — 169 266 Impairment charges — — 120,470 — — Adjusted EBITDA (numerator for ROIC) (non-GAAP) $ 27,732 $ 19,743 $ 12,321 $ 19,845 $ 33,019 Invested Capital Calculation Equity - beginning of the quarter $ 671,227 $ 678,246 $ 897,678 $ 927,580 $ 905,751 Equity - end of quarter 682,139 671,227 678,246 897,678 927,580 Adjustments: Change in fair value of contingent consideration, net of tax — 390 510 467 2,401 Tax recovery, net and related interest income, net of tax — — (6,247) (1,754) — Acquisition and divestiture costs 1,359 498 1,311 781 1,151 Asset impairment, net of tax — — 114,398 — — Restructuring costs, net of tax 366 6,250 — 125 196 Discontinued operations net loss 25,255 11,704 108,403 4,003 260 Average equity 690,173 684,158 897,150 914,440 918,670 Average funded debt (b) 198,620 243,268 337,973 405,533 411,614 Invested capital (denominator for ROIC) (non-GAAP) $ 888,793 $ 927,426 $ 1,235,123 $ 1,319,973 $ 1,330,284 (a) Calculated as net income plus interest expense, income taxes, depreciation and amortization (EBITDA), annualized divided by invested capital for the period. Adjusted EBITDA reflects other adjustments for non-GAAP measures. (b) Average funded debt, which includes both continuing and discontinued operations, is calculated as the daily average amounts outstanding on our short-term and long-term interest-bearing debt. ScanSource, Inc. CFO COMMENTARY Q2 FY2021 APPENDIX: RECONCILIATIONS FOR NON-GAAP FINANCIAL INFORMATION scansource.com 15 February 2, 2021
Net Debt and EBITDA Metrics ($ in thousands) Q2 FY21 Q1 FY21 Q4 FY20 Q3 FY20 Q2 FY20 Debt of continuing operations(Q/E) $ 151,924 $ 148,799 $ 218,728 $ 281,951 $ 280,791 Debt of discontinued operations (Q/E) — 19,932 28,228 38,645 76,954 Consolidated debt (Q/E) 151,924 168,731 246,956 320,596 357,745 Less: Cash and cash equivalents of continuing operations (Q/E) (67,187) (49,889) (29,485) (29,758) (38,773) Cash and cash equivalents of discontinued operations (Q/E) — (5,678) (4,970) (4,838) (3,232) Consolidated cash and cash equivalents (Q/E) (67,187) (55,567) (34,455) (34,596) (42,005) Net debt (Q/E) $ 84,737 $ 113,164 $ 212,501 $ 286,000 $ 315,740 Reconciliation of Net Income to Adjusted EBITDA Net income (loss) from continuing operations - GAAP $ 11,061 $ (115) $ (108,859) $ 5,716 $ 11,626 Plus: Interest expense 1,796 1,913 2,497 3,098 3,312 Income taxes 4,683 (47) (4,091) 2,797 4,407 Depreciation and amortization 8,349 8,710 8,743 8,986 9,081 EBITDA 25,889 10,461 (101,710) 20,597 28,426 Adjustments: Change in fair value of contingent consideration — 516 674 618 3,176 Tax recovery, net — — (8,424) (2,320) — Acquisition and divestiture costs 1,359 498 1,311 781 1,151 Restructuring costs 484 8,268 — 169 266 Impairment charges — — 120,470 — — Adjusted EBITDA (non-GAAP) $ 27,732 $ 19,743 $ 12,321 $ 19,845 $ 33,019 Adjusted EBITDA, TTM (a) $ 79,642 $ 84,929 $ 97,047 $ 119,925 $ 135,627 Net Debt / Adjusted EBITDA, TTM (a) 1.1x 1.3x 2.2x 2.4x 2.3x (a) Adjusted EBITDA for the trailing 12-month period ScanSource, Inc. CFO COMMENTARY Q2 FY2021 APPENDIX: RECONCILIATIONS FOR NON-GAAP FINANCIAL INFORMATION scansource.com 16 February 2, 2021
Discontinued Operations, Net Sales and Working Capital ($ in thousands) Q2 FY21 Q1 FY21 Q4 FY20 Q3 FY20 Q2 FY20 Net sales from continuing operations $ 810,897 $ 757,342 $ 636,450 $ 744,584 $ 823,999 Net sales from discontinued operations 68,323 145,049 121,969 127,899 155,912 Working capital Net accounts receivable of continuing operations $ 534,583 $ 509,779 $ 443,185 $ 504,366 $ 513,644 Net accounts receivable of discontinued operations — 130,553 117,200 114,392 131,626 Inventory of continuing operations $ 421,003 $ 423,088 $ 454,885 $ 550,072 $ 621,146 Inventory of discontinued operations — 95,560 106,779 116,386 121,833 Accounts payable of continuing operations $ 589,292 $ 544,856 $ 454,240 $ 533,124 $ 586,957 Accounts payable of discontinued operations — 84,657 56,098 75,293 85,949 Working capital of continuing operations $ 366,294 $ 388,011 $ 443,830 $ 521,314 $ 547,833 Working capital of discontinued operations — 141,456 167,881 155,485 167,510 ScanSource, Inc. CFO COMMENTARY Q2 FY2021 APPENDIX: RECONCILIATIONS FOR NON-GAAP FINANCIAL INFORMATION scansource.com 17 February 2, 2021